Arkema acquires 100% stake in Casda Biomaterials - MarketLine Financial Deals

Arkema acquires 100% stake in Casda Biomaterials

Arkema acquires 100% stake in Casda Biomaterials - MarketLine Financial Deals
Arkema acquires 100% stake in Casda Biomaterials
Published Feb 01, 2012
3 pages — Published Feb 01, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Arkema SA, a France-based manufacturer of industrial chemicals, has acquired 100% stake in Casda Biomaterials, a manufacturer of sebacic acid, from Jiangsu Feixiang Chemical Co., Ltd. and Bain Capital

  
Source:
Document ID
MA88434_111122
Country
Country
Ticker
AKE=FR
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Arkema acquires 100% stake in Casda Biomaterials" Feb 01, 2012. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Arkema-acquires-100-stake-in-Casda-Biomaterials-2052-73604>
  
APA:
MarketLine Financial Deals. (2012). Arkema acquires 100% stake in Casda Biomaterials Feb 01, 2012. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Arkema-acquires-100-stake-in-Casda-Biomaterials-2052-73604>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.